Patents Represented by Law Firm Cooley Godward Castro Huddleson & Tatum
  • Patent number: 5517125
    Abstract: A reusable carrier (10) for temporarily holding an integrated circuit (12) during burn-in and electrical test includes a base (14) and a lid (16) attached to the base (14) by hinges (18). A flexible substrate (19) is attached to the base (14) with a suitable adhesive. Alignment posts (20) have tapered surfaces (22) that engage corners (24) of the integrated circuit (12) to position the integrated circuit (12) precisely on upper surface (26) of the substrate (19). A spring-loaded latch (28) engages projection (30) in aperture (32) of the base (14) to hold the lid (16) closed over the integrated circuit (12). Electrically conductive traces (34) on the surface (26) have contact bumps which engage contact pads on the underside of the circuit (12) to connect the integrated circuit (12) to peripheral contact pads (38) around edges (40) of the substrate (19).
    Type: Grant
    Filed: July 9, 1993
    Date of Patent: May 14, 1996
    Assignee: AEHR Test Systems, Inc.
    Inventors: Rhea Posedel, Larry Lape, James Wrenn
  • Patent number: 5510261
    Abstract: A neuraminidase enzyme with unusually high activity under extracellular culture conditions has been discovered in Chinese hamster ovary (CHO) cells and other types of cells. By affecting the neuraminidase activity of the cell culture, the degradation of glycoprotein oligosaccharides produced by these cultured cells can be controlled.
    Type: Grant
    Filed: January 12, 1995
    Date of Patent: April 23, 1996
    Assignee: The Board of Trustees of the Leland Stanford Juniot University
    Inventors: Charles F. Goochee, Michael J. Gramer
  • Patent number: 5496724
    Abstract: An assay for screening snake venom for the presence or absence of platelet aggregation inhibitors (PAIs) based on specific receptor binding is described. Using this assay, the identification and characterization of PAIs in a wide range of snake venom samples was accomplished. The isolated and purified PAI from several of these active snake venoms is described and characterized. In addition, PAIs lacking the Arg-Gly-Asp (RGD) adhesion sequence but containing K*-(G/Sar)-D wherein K* is a modified lysyl residue of the formulaR.sup.1.sub.2 N(CH.sub.2).sub.4 CHNHCO--wherein each R.sup.1 is independently H, alkyl(1-6C) or at most one R.sup.1 is R.sup.2 --C.dbd.NR.sup.3 wherein R.sup.2 is H, alkyl(1-6C) or is NR.sup.4.sub.2 in which each R.sup.4 is independently H or alkyl(1-6C) and R.sup.3 is H, alkyl(1-6C), phenyl or benzyl, or R.sup.2 --C.dbd.NR.sup.3 is a radical selected from the group consisting of: ##STR1## where m is an integer of 2-3, and each R.sup.
    Type: Grant
    Filed: May 24, 1993
    Date of Patent: March 5, 1996
    Assignee: COR Therapeutics, Inc.
    Inventors: Robert M. Scarborough, David L. Wolf, Israel F. Charo
  • Patent number: 5480776
    Abstract: A method for detecting the onset of labor in a patient, which comprises analyzing a body fluid of the patient for estriol concentration; correlating the concentration with a standard value; and relating a higher concentration of estriol relative to the standard value as an indication of potential onset of pre-term labor. The standard is usually selected from the group consisting of (1) a predetermined range of estriol concentrations for the body fluid in normal pregnant humans at a preselected time relative to normal, full-term delivery, or (2) a previously measured estriol concentration of the same body fluid of the same pregnant human. Use of this method does not require determination of an estriol/progesterone concentration ratio in the body fluid being test.
    Type: Grant
    Filed: May 12, 1994
    Date of Patent: January 2, 1996
    Assignee: Biex, Inc.
    Inventor: Vivian K. Dullien
  • Patent number: 5479266
    Abstract: Screen (10) for a user interface of a television schedule system and process consists of an array (24) of irregular cells (26), which vary in length, corresponding to different television program lengths of one half hour to one-and-one half hours or more. The array is arranged as three columns (28) of one-half hour in duration, and twelve rows (30) of program listings. Some of the program listings overlap two or more of the columns (28) because of their length. Because of the widely varying length of the cells (26), if a conventional cursor used to select a cell location were to simply step from one cell to another, the result would be abrupt changes in the screen (10) as the cursor moved from a cell (26) of several hours length to an adjacent cell in the same row. An effective way of taming the motion is to assume that behind every array (24) is an underlying array of regular cells. By restricting cursor movements to the regular cells, abrupt screen changes will be avoided.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 26, 1995
    Assignee: Starsight Telecast Inc.
    Inventors: Patrick Young, John H. Roop, Allan R. Ebright, Michael W. Faber, David Anderson
  • Patent number: 5479268
    Abstract: Screen (10) for a user interface of a television schedule system and process consists of an array (24) of irregular cells (26), which vary in length, corresponding to different television program lengths of one half hour to one-and-one half hours or more. The array is arranged as three columns (28) of one-half hour in duration, and twelve rows (30) of program listings. Some of the program listings overlap two or more of the columns (28) because of their length. Because of the widely varying length of the cells (26), if a conventional cursor used to select a cell location were to simply step from one cell to another, the result would be abrupt changes in the screen (10) as the cursor moved from a cell (26) of several hours length to an adjacent cell in the same row. An effective way of taming the motion is to assume that behind every array (24) is an underlying array of regular cells. By restricting cursor movements to the regular cells, abrupt screen changes will be avoided.
    Type: Grant
    Filed: February 18, 1994
    Date of Patent: December 26, 1995
    Assignee: Starsight Telecast Inc.
    Inventors: Patrick Young, John H. Roop, Allan R. Ebright, michael W. Faber, David Anderson
  • Patent number: 5473060
    Abstract: Compounds referred to herein as oligonucleotide clamps are provided that stably bind to target polynucleotides in a sequence-specific manner. The oligonucleotide clamps comprise one or more oligonucleotide moieties capable of specifically binding to a target polynucleotide and one or more pairs of binding moieties covalently linked to the oligonucleotide moieties. In accordance with the invention, upon annealing of the oligonucleotide moieties to the target polynucleotide, the binding moieties of a pair are brought into juxtaposition so that they form a stable covalent or non-covalent linkage or complex. The interaction of the binding moieties of the one or more pairs effectively clamps the specifically annealed oligonucleotide moieties to the target polynucleotide.
    Type: Grant
    Filed: July 2, 1993
    Date of Patent: December 5, 1995
    Assignee: Lynx Therapeutics, Inc.
    Inventors: Sergei M. Gryaznov, David H. Lloyd
  • Patent number: 5472844
    Abstract: Genetic material encoding the P22 peptide of Toxoplasma gondii has been isolated and characterized. This genetic material allows the production of peptides for use in diagnosis or immunization or can itself be directly used in hybridization assays.
    Type: Grant
    Filed: October 25, 1994
    Date of Patent: December 5, 1995
    Assignee: Research Institute of Palo Alto Medical Foundation
    Inventors: Fausto G. De Araujo, Jeffrey B. Prince, Jack S. Remington
  • Patent number: 5471382
    Abstract: In a medical network management system (NMS) (20), health plan beneficiaries access a team of health care professionals over the telephone to help them assess their health needs and select appropriate care. The NMS (20) has a patient assessment component (22). The patient assessment component consists of a set of information tools which are used by health care professionals to assess patient conditions and assist in the selection of health care services and to help patients find appropriate care at the appropriate time. The tools include a comprehensive, automated set of proprietary assessment algorithms (26) which are based on branched chain algorithms utilizing Bayes theorem. These unique, clinical tools enable a trained nurse or other health care professional to sort patients into different risk categories, safely and effectively without requiring a medical diagnosis.
    Type: Grant
    Filed: January 10, 1994
    Date of Patent: November 28, 1995
    Assignee: Informed Access Systems, Inc.
    Inventors: Joseph P. Tallman, Elizabeth M. Snowden, Barry W. Wolcott
  • Patent number: 5466469
    Abstract: A novel granular drug delivery system having a gel-forming dietary fiber that can be made into a an orally-ingestible dispersion by admixture with a liquid that can deliver an effective dose of a pharmaceutically-active compound. The granular drug delivery system comprises granules consisting essentially of a pharmaceutically active compound, and a gel-forming dietary fiber, the granules being coated with at least one of the following: a gel-forming dietary fiber, a starch or a protein. The composition may further include a mineral salt that releases a physiologically-acceptable gas upon ingestion. The composition of the granular drug delivery system will deliver microgram quantities of a pharmaceutically-active compound in an orally-ingestible dispersion without forming a thick gel and without forming "hot" and "cold" spots of the pharmaceutically-active compound.
    Type: Grant
    Filed: March 28, 1994
    Date of Patent: November 14, 1995
    Assignee: Cibus Pharmaceutical, Inc.
    Inventor: Eric H. Kuhrts
  • Patent number: 5463911
    Abstract: A gearshift sleeve actuating apparatus for a stepped automotive gearbox is disclosed. The apparatus comprises a shift rod which can be displaced along its axis. A shift fork and an engaging piece or driver are rigidly arranged on the shift rod. The apparatus is configured as a composite plastic/metal structure in which a metal component, constituting the engaging piece as well as a core for the shift rod, is injection-embedded in a plastic material. The shift fork consists exclusively of the plastic material.
    Type: Grant
    Filed: July 7, 1994
    Date of Patent: November 7, 1995
    Assignee: Getrag Gestriebe-und Zahnradfabrik Hermann Hagenmeyer GmbH & Cie
    Inventors: Gunter Knoedel, Reinhard Schaarschmidt
  • Patent number: 5456985
    Abstract: The present invention relates to micro-capsules constituted by a solid envelope consisting of a layer of coating materials including at least one gastro-resistant polymer, said solid envelope containing an oily liquid.
    Type: Grant
    Filed: July 14, 1993
    Date of Patent: October 10, 1995
    Inventors: Slim Zgoulli, Philippe Delfosse, Philippe Thonart, Dominique Delacroix
  • Patent number: 5445826
    Abstract: A prolonged-release unit dosage formulation or pharmaceutical composition, preferably in tablet form, is described. The composition consists essentially of a gel-forming fiber, preferably hydrocolloid-coated, a biologically-absorbable drug or other active therapeutic agent which is also preferably hydrocolloid-coated, a mineral salt which releases a physiologically-acceptable gas upon ingestion, preferably carbon dioxide, e.g., a mineral carbonate or bicarbonate, and optionally an organic or phosphoric acid and a dextrose or like soluble sugar. The fiber-containing composition, when in the form of a tablet or other unit dosage form together with the drug or agent and the stated disintegrants, provides a unique, efficient and controllable prolonged-action drug-delivery system.
    Type: Grant
    Filed: December 14, 1993
    Date of Patent: August 29, 1995
    Assignee: Cibus Pharmaceutical, Inc.
    Inventor: Eric H. Kuhrts
  • Patent number: 5440749
    Abstract: A microprocessor (50) includes a main central processing unit (CPU) (70) and a separate direct memory access (DMA) CPU (72) in a single integrated circuit making up the microprocessor (50). The main CPU (70) has a first 16 deep push down tack (74), which has a to item register (76) and a next item register (78), respectively connected to provide inputs to an arithmetic logic unit (ALU) (80) by lines (82) and (84). An output of the ALU (80) is connected to the top item register at (82) is also connected by line (88) to an internal data bus (90). CPU (70) is pipeline free. The simplified CPU (70) requires fewer transistors to implement than pipelined architectures, yet produces performance which matches or exceeds existing techniques. The DMA CPU (72) provides inputs to the memory controller (118) on line (148). The memory controller (118) is connected to a RAM by address/data bus (150) and control lines (152).
    Type: Grant
    Filed: August 3, 1989
    Date of Patent: August 8, 1995
    Assignee: Nanotronics Corporation
    Inventors: Charles H. Moore, Russell H. Fish, III
  • Patent number: 5437990
    Abstract: A method is provided for multiplying the number of copies of a target polynucleotide sequence comprising a series of primer hybridization, extending, and denaturing steps to provide an intermediate double-stranded DNA molecule containing a promoter sequence (through the use of a promoter-sequence-containing primer) incorporated upstream from the target sequence. The double-stranded DNA intermediate is then used to grow multiple RNA copies of the target sequence. The resulting RNA copies can be used as target sequences to produce further copies. Multiple cycles of this sort can thereby exponentially increase the number of target sequence copies.
    Type: Grant
    Filed: September 13, 1993
    Date of Patent: August 1, 1995
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: James L. Burg, Philippe J. Pouletty, John C. Boothroyd
  • Patent number: 5429510
    Abstract: A high density interconnect system (30) employs contact fingers (32) on both surfaces (34) and (36) of burn-in PCB (38), feed-through PCB (40) and driver PCB (42). Each of the PCBs (38), (40) and (42) has a card-edge connector (44), (46) and (48). The feed-through PCB (40) has a second card-edge connector (40) and a second set of contact fingers (32), since it mates with both the burn-in PCB (38) and the driver PCB (42). The contact fingers (32) and the card-edge connectors (44), (46), (48) and (50) of each PCB (38), (40) and (42) mate inversely with each other on adjacent PCBs, i.e., the card-edge connector (44) of the burn-in PCB (38) mates with the contact fingers (32) of the feed-through PCB (40), and the card-edge connector (46) of the feed-through PCB (40) mates with the contact fingers (32) of the burn-in PCB (38), for example.
    Type: Grant
    Filed: December 1, 1993
    Date of Patent: July 4, 1995
    Assignee: Aehr Test Systems, Inc.
    Inventors: William D. Barraclough, Mikhail A. Alperin, Jeffrey A. Brehm, John D. Hoang, Patrick M. Shepherd, James F. Tomic
  • Patent number: 5417972
    Abstract: Methods are provided for inducing cell death in B-cells, including neoplastic B-cells, by employing reagents that bind to a B-cell epitope. Particularly, antibodies specific for the marker can be administered to a host to induce death in B-cells to which the antibodies bind or can be used in ex vivo clinical situations to selectively remove B-cells. A B-cell specific oligosaccharide epitope useful as a B-cell marker has been identified. The ligand being recognized on B lymphocytes has no apparent similarities to any of the known pan-B cells markers. In addition, proteins which specifically bind the disclosed epitope are provided. Human monoclonal antibody 216, which recognizes this B-cell epitope, is cytotoxic to B-cells and binds all CD19.sup.+ and CD20.sup.+ B lymphocytes in human peripheral blood and spleen. Furthermore, MAb 216 does not distinguish B cells by the isotype expressed, binding IgG.sup.+ and IgM.sup.+ cells with equal intensity, and also bind all B cells regardless of their CD5 expression.
    Type: Grant
    Filed: August 2, 1993
    Date of Patent: May 23, 1995
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Neelima M. Bhat, Marcia M. Bieber, Nelson N. H. Teng
  • Patent number: 5415995
    Abstract: A series of seventeen synthetic peptides which are capable of raising antibodies specific for certain desired human papilloma virus (HPV) are useful in diagnosis and therapy of conditions associated with HPV infection.
    Type: Grant
    Filed: July 6, 1992
    Date of Patent: May 16, 1995
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Gary K. Schoolnik, Joel M. Palefsky
  • Patent number: D361507
    Type: Grant
    Filed: October 13, 1993
    Date of Patent: August 22, 1995
    Inventor: Johannes Langemann
  • Patent number: RE35224
    Abstract: Histamine derivatives are disclosed which find use as effect and tissue-specific immune modulators. Specifically, the primary terminal nitrogen in histamine is derivatized to introduce a variable length side chain having 0 to 1 branch of from 1 to 3 carbons; 0 to 2 non-oxo-carbonyl groups; 0 to 4 heteroatoms, other than the non-oxo carbonyl oxygen; 0 to 1 aryl or alkylaryl group; and 0 to 1 functionally bound amino acid, polypeptide, or protein or derivative thereof.
    Type: Grant
    Filed: February 26, 1993
    Date of Patent: April 30, 1996
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Kenneth L. Melmon, Murray Goodman, Manzoor M. Khan, Debra Marr-Leisy, Michael Verlander